In a victory for Enfamil manufacturer Mead Johnson, a Missouri state court jury rejected claims that the company’s specialized cow’s milk-based formula for premature infants was responsible for an infant’s dangerous bowel disease, necrotizing enterocolitis. (NEC)
The lawsuit was brought by an Illinois mother who claimed her daughter was left with lifelong injuries after she contracted NEC as a result of consuming Mead Johnson’s infant nutrition product.
It was one of nearly 1,000 similar lawsuits filed against Mead Johnson and Abbott Laboratories, which makes Similac formulas. More than 700 of the cases are centralized in an Illinois federal court, with others pending in state courts including Illinois, Missouri and Pennsylvania.
“We strongly reject any assertion that any of our specialized preterm hospital nutrition products cause NEC,” Mead Johnson said in a statement.
In June, an Illinois appeals court reversed a $60 million verdict against Mead Johnson in another trial in which the company was accused of failing to warn that its products for premature babies could cause NEC.
The Illinois Fifth District Appellate Court granted Mead Johnson a new trial in Watson v. Mead Johnson Company, LLC, saying the jury had not been properly instructed on the law. The appellate court found that the trial court made reversible errors, including problems with the jury instructions on failure to warn and the admission of testimony concerning Mead Johnson’s corporate wealth.
A new lawsuit was filed against Mead Johnson and Abbott Laboratories by a Nevada family who alleges that cow’s milk-based infant feeding products caused their premature child to develop NEC.
The family claims the child was born at approximately 29 weeks’ gestation, weighing about 1,620 grams. The child was initially fed breast milk but was soon transitioned to Mead Johnson’s Enfamil Human Milk Fortifier and Enfamil formula, both cow’s milk-based products. The lawsuit alleges that shortly after ingesting those products, the child was diagnosed with NEC.